IQVIA™ Real-World Insights Bibliography

The Certainty Framework for Assessing Real?World Data in Studies of Medical Product Safety and Effectiveness
Author(s): Noelle M. Cocoros Peter Arlett Nancy A. Dreyer Chieko Ishiguro Solomon Iyasu Miriam Sturkenboom Wei Zhou Sengwee Toh
Affiliations(s): 1Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA. 2Data Analytics and Methods Task Force, European Medicines Agency, Amsterdam, The Netherlands. 3London School of Hygiene and Tropic Medicine, London, UK. 4Center for Advanced Evidence Generation, IQVIA Real World Solutions, Cambridge, Massachusetts, USA. 5Division of Epidemiology, Office of Medical Informatics and Epidemiology, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan. 6Center for Observational and Real-world Evidence, Merck & Co., Inc., Kenilworth, New Jersey, USA. 7Julius Center, Global Health, University Medical Center Utrecht, Utrecht, The Netherlands.
Publication(s):  https://doi.org/10.1002/cpt.2045
Document Type(s): Article,
Countries: Japan, Netherlands, USA,
Click here for the abstract
C:
Y:
Health status & patient reported outcomes,
2020
  L:
A:
English
direct to patient research, Real World Data, Real World Evidence,
  Add to report
 
 
Methods for external control groups for single arm trials or long-term uncontrolled extensions to randomized clinical trials
Author(s): John D Seeger 1, Kourtney J Davis 2, Michelle R Iannacone 3, Wei Zhou 4, Nancy Dreyer 5, Almut G Winterstein 6, Nancy Santanello 7, Barry Gertz 8, Jesse A Berlin 2
Affiliations(s): 1Life Sciences Epidemiology, Optum, Boston, Massachusetts, USA. 2Global Epidemiology, Johnson & Johnson, Titusville, New Jersey, USA. 3Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA. 4Pharmacoepidemiology, Merck & Co., Inc., Kenilworth, New Jersey, USA. 5Real-World Solutions, IQVIA, Cambridge, Massachusetts, USA. 6University of Florida, Gainesville, Florida, USA. 7Nancy Santanello Research Consultant, Philadelphia, Pennsylvania, USA. 8Blackstone, Cambridge, Massachusetts, USA.
Publication(s):  PMID: 32964514 PMCID: PMC7756307 DOI: 10.1002/pds.5141 Published online 2020 Oct 4. doi: 10.1002/pds.5141
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Guidelines,
2020
  L:
A:
English
Epidemiological study, Real World Data, Real World Evidence,
  Add to report
 
 
High clinician- and patient-reported satisfaction with individualized onabotulinumtoxinA treatment for spasticity across several etiologies from the ASPIRE study
Author(s): Gerard E Francisco 1, Daniel S Bandari 2, Ganesh Bavikatte 3, Wolfgang H Jost 4 5, Emily McCusker 6, Joan Largent 7, Aleksej Zuzek 6, Alberto Esquenazi 8
Affiliations(s): 1The University of Texas Health Science Center McGovern Medical School and TIRR Memorial Hermann, Houston, TX, USA. 2Multiple Sclerosis Center of California & Research Group, Newport Beach, CA, USA. 3The Walton Centre, Liverpool, UK. 4University of Freiburg, Department of Neurology, Freiburg im Breisgau, Germany. 5Parkinson-Klinik Ortenau, Wolfach, Germany. 6Allergan, an AbbVie Company, Irvine, CA, USA. 7IQVIA Real-World Evidence Solutions, Cambridge, MA, USA. 8MossRehab Gait and Motion Analysis Laboratory, Elkins Park, PA, USA.
Publication(s):  PMID: 32875289 PMCID: PMC7452133 DOI: 10.1016/j.toxcx.2020.100040
Document Type(s): Article,
Countries: Europe, USA,
Click here for the abstract
C:
Y:
Neurological disorders,
2020
  L:
A:
English
Epidemiological study, Observational study,
  Add to report
 
 
Individualized OnabotulinumtoxinA Treatment for Upper Limb Spasticity Resulted in High Clinician- and Patient-Reported Satisfaction: Long-Term Observational Results from the ASPIRE Study
Author(s): Gerard E Francisco 1, Wolfgang H Jost 2, Ganesh Bavikatte 3, Daniel S Bandari 4, Simon F T Tang 5, Michael C Munin 6, Joan Largent 7, Aubrey M Adams 8, Aleksej Zuzek 8, Alberto Esquenazi 9
Affiliations(s): 1The University of Texas Health Science Center McGovern Medical School and TIRR Memorial Hermann, Houston, TX. 2Department of Neurology, University of Freiburg, Freiburg im Breisgau, Germany. 3The Walton Centre, Liverpool, UK. 4Multiple Sclerosis Center of California & Research Group, Newport Beach, CA. 5Department of Physical Medicine and Rehabilitation, Lotung Poh-Ai Hospital, Yilan, Taiwan. 6Department of Physical Medicine and Rehabilitation, University of Pittsburgh School of Medicine, Pittsburgh, PA. 7IQVIA Real-World Evidence Solutions, Cambridge, MA. 8Allergan plc, Irvine, CA. 9MossRehab Gait and Motion Analysis Laboratory, Elkins Park, PA.
Publication(s):  PMID: 31953896 PMCID: PMC7687094 DOI: 10.1002/pmrj.12328
Document Type(s): Article,
Countries: Asia Pacific, Europe, USA,
Click here for the abstract
C:
Y:
Neurological disorders,
2020
  L:
A:
English
Epidemiological study, Observational study,
  Add to report
 
 
Multicenter Prospective Evaluation of Parenteral Nutrition Preparation Time and Resource Utilization: 3-Chamber Bags Compared With Hospital Pharmacy-Compounded Bags
Author(s): Sarah V Cogle 1 2, Robert G Martindale 3, Mafalda Ramos 4, Gregory J Roberti 5, Pamela R Roberts 6, Kaci Taylor 7, Gordon S Sacks 1 8
Affiliations(s): 1Department of Pharmacy Practice, Auburn University, Auburn, Alabama, USA. 2Department of Pharmacy, East Alabama Medical Center, Opelika, Alabama, USA. 3Department of Surgery, Oregon Health and Science University, Portland, Oregon, USA. 4IQVIA, Zaventem, Belgium. 5Department of Pharmacy, Oregon Health and Science University, Portland, Oregon, USA. 6Department of Anesthesiology, University of Oklahoma College of Medicine, Oklahoma City, Oklahoma, USA. 7Department of Pharmacy, OU Medical Center, Oklahoma City, Oklahoma, USA. 8Medical Affairs, Fresenius Kabi, LLC, Lake Zurich, Illinois, USA.
Publication(s):  Journal of Parenteral and Enteral Nutrition Volume 0 Number 0 November 2020 1?7 DOI: 10.1002/jpen.2045
PMID: 33188572 DOI: 10.1002/jpen.2045
Document Type(s): 
Countries: USA,
Click here for the abstract
C:
Y:
Health economics, Neurological disorders,
2020
  L:
A:
English
Clinical setting: hospital, Cost effectiveness, Prospective study,
  Add to report
 
 
Budget IMPACT Analysis of a Reduced Maintenance Dose of Certolizumab Pegol in Patients with Axial Spondyloarthritis in the United Kingdom
Author(s): Kiri S, Arteaga Duarte C, Lamotte M, Gerlier L
Affiliations(s): IQVIA HEOR Zaventem
Publication(s):  ISPOR Europe 2020 Virtual conference Milano Nov 16-19 Abstract ID# 107821
Document Type(s): Poster,
Countries: USA,
C:
Y:
Rheumatology,
2020
  L:
A:
English
clinical setting: Secondary care, Cost effectiveness,
  Add to report
 
 
Cost-Effectiveness Analysis of Certolizumab Pegol Versus Secukinumab and Ixekizumab in Non-Radiographic Axial Spondyloarthritis in the U.S
Author(s): Kiri S, Arteaga Duarte Ca, Lee E, Low R, Tsakeu E, Lamotte M, Gerlier L.
Affiliations(s): IQVIA HEOR Zaventem
Publication(s):  AMCP Nexus 2020 Virtual October 19.
Document Type(s): Poster,
Countries: USA,
C:
Y:
Rheumatology,
2020
  L:
A:
English
clinical setting: Secondary care, Cost effectiveness,
  Add to report
 
 
Modernizing Regulatory Evidence with Trials and Real-World Studies
Author(s): Nancy A. Dreyer PhD, MPH, FISPE, Marni Hall PhD, MPH & Jennifer B. Christian PharmD, MPH, PhD, FISPE
Affiliations(s): IQVIA Real World Solutions, 201 Broadway, 5th Floor, Cambridge, MA, 02139, USA Nancy A. Dreyer PhD, MPH, FISPE IQVIA Real-World Solutions, Rockville, MD, USA Marni Hall PhD, MPH IQVIA Real World Solutions, Research Triangle Park, NC, USA Jennifer B. Christian PharmD, MPH, PhD, FISPE
Publication(s):  Ther Innov Regul Sci (2020). https://doi.org/10.1007/s43441-020-00131-5
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Oncology,
2020
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Natural hisotry of oral human papillomavirus infection in healthy populations: Design of the Prevalence of Oral HPV infection, a Global assessment, THE PROGRESS STUDY
Author(s): Pedros M1, Morais E2, Roset M1, Kothari S3, Alemany L5, Mirghani H6, Mehanna H7, Waterboer T8, Roberts C3, Vendetti N3, Walia A3, Drury R2, Luxembourg A3, Giuliano A9
Affiliations(s): 1 IQVIA, Barcelona, Spain 2 MSD, Lyon, France 3 Merck & Co, Inc., Kenilworth, NJ, US 5 Catalan Institute of Oncology, Cancer Epidemiology Research Program and IDIBELL i CIBERESP, Barcelona, Spain 6 Hôpital Européen Georges-Pompidou Université Paris-Descartes, Paris, France 7 Institute of Head & Neck Studies and Education (InHANSE), University of Birmingham, Birmingham, United kingdom 8 German Cancer Research Center (DKFZ), Heidelberg, Germany 9 Moffitt Cancer Center, Florida, US
Publication(s):  EUROGIN, Monaco, France, 4-7 December 2019
Document Type(s): Oral presentation,
Countries: China, France, Germany, Italy, Japan, Spain, UK, USA,
Click here for the abstract
C:
Y:
Clinical practice, Infectious disease, Methodology,
2019
  L:
A:
English
Epidemiological study, Observational study, Population Based Study,
  Add to report
 
 
Registries for Evaluating Patient Outcomes: A User?s Guide (Prepared by the Outcome DEcIDE Center [Outcome Sciences, Inc., a Quintiles company] under Contract No. 290 2005 00351 TO7.) AHRQ Publication No. 13(14)-EHC111. Rockville, MD: Agency for Healthcare Research and Quality. April 2014. 1st edition, April 2007; 2nd Edition, September, 2010; Third edition, 2014. also available in Korean (Korean National Evidence-based Healthcare Collaborating Agency, published December 2010), and in Chinese (University of Peking, published December 2012). 4th edition, in press, 2019.
Author(s): Gliklich R, Dreyer N, Leavy M, eds.
Affiliations(s): 
Publication(s): 
Document Type(s): Book,
Countries: USA,
C:
Y:

2019
  L:
A:
English
  Add to report
 
 
First Page Previous Page  3 of 66 Next Page Last Page